n-Lorem Foundation logo — Creating a better future for nano-rare, one patient at a tim...

n-Lorem Foundation

Creating a better future for nano-rare, one patient at a time.

Founded 2020 United States Carlsbad, United States 34 employees Grant Total: $1.00M Health Care, Health and Wellness

General Information

Company Name n-Lorem Foundation
Founded Year 2020
Location United States Carlsbad, United States
Employees 34
Industries Health Care, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with n-Lorem Foundation. To contact n-Lorem Foundation, visit nlorem.org.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does n-Lorem Foundation compare?

A PDF of n-Lorem Foundation and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting n-Lorem Foundation soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About n-Lorem Foundation

n-Lorem Foundation is a health care and health and wellness startup founded in 2020. The company's slogan, "Creating a better future for nano-rare, one patient at a time," reflects its dedication to providing personalized experimental ASO medicines to treat nano-rare patients — for free, for life. Recently, the company received a $1.00M Grant investment from Solve FSHD on 13 September 2022. n-Lorem Foundation's innovative approach to addressing the needs of nano-rare patients presents a compelling opportunity for potential investors in the health care sector.

Business keywords: Rare Diseases, Personalized Medicine, Antisense Technology, Experimental Medicines, Nanotechnology, Healthcare Innovation, Patient-Centric, Precision Medicine, Therapeutic Development, Medical Research, Non-profit Organization, RNA Therapeutics

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant N $1.00M 1
Solve FSHD
13 Sep 2022

n-Lorem Foundation Alternatives & Competitors

View All Alternatives
n-Lorem Foundation vs

Silencing genes for life

Post-IPO Equity
16 employees
Biotechnology, Health Care
n-Lorem Foundation vs

Bringing transformative therapies to patients with severe RNA-mediated diseases.

Venture round
29 employees
Biotechnology, Health Care
n-Lorem Foundation vs

At Avidity, we are developing a new class of oligonucleotide-based therapies.

IPO
447 employees
Biotechnology, Health Care

FAQ About n-Lorem Foundation

Creating a better future for nano-rare, one patient at a time.
n-Lorem Foundation was founded in 2020.
n-Lorem Foundation is headquartered in Carlsbad, United States.
n-Lorem Foundation operates in Health Care and Health and Wellness. Its work centres on Rare Diseases, Personalized Medicine, Antisense Technology and Experimental Medicines.
n-Lorem Foundation has approximately 34 employees.
n-Lorem Foundation has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Grant.
Top alternatives and competitors to n-Lorem Foundation include Benitec Biopharma Inc., Expansion Therapeutics, Avidity Biosciences, Inc., Rona Therapeutics, ImmunAbs Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
n-Lorem Foundation and Benitec Biopharma Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for n-Lorem Foundation, https://bouncewatch.com/company/n-lorem-foundation, updated 6 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes